US Stock MarketDetailed Quotes
GPCR Structure Therapeutics
- 33.770
- -0.720-2.09%
Close Aug 9 16:00 ET
- 34.000
- +0.230+0.68%
Post 20:01 ET
1.93BMarket Cap-19242P/E (TTM)
35.970High32.570Low769.47KVolume35.970Open34.490Pre Close25.95MTurnover1.57%Turnover RatioLossP/E (Static)57.20MShares75.01752wk High2.10P/B1.66BFloat Cap25.57052wk Low--Dividend TTM49.05MShs Float75.017Historical High--Div YieldTTM9.86%Amplitude20.800Historical Low33.726Avg Price1Lot Size
Structure Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 28.20%33.32M | 62.93%32.02M | 95.53%102.78M | 139.23%30.99M | 105.98%26.15M | 86.15%25.99M | 51.71%19.65M | 39.43%52.56M | -2.40%12.96M | 12.69M |
| Selling and administrative expenses | 71.32%11.27M | 74.03%11.34M | 99.61%32.67M | 138.29%10.95M | 144.27%8.63M | 74.01%6.58M | 46.05%6.51M | 90.66%16.37M | 36.50%4.6M | --3.53M |
| -General and administrative expense | 71.32%11.27M | 74.03%11.34M | 99.61%32.67M | 138.29%10.95M | 144.27%8.63M | 74.01%6.58M | 46.05%6.51M | 90.66%16.37M | 36.50%4.6M | --3.53M |
| Research and development costs | 13.60%22.05M | 57.43%20.68M | 93.69%70.1M | 139.74%20.04M | 91.21%17.52M | 90.66%19.41M | 54.67%13.14M | 24.33%36.19M | -15.62%8.36M | --9.16M |
| Operating profit | -28.20%-33.32M | -62.93%-32.02M | -95.53%-102.78M | -139.23%-30.99M | -105.98%-26.15M | -86.15%-25.99M | -51.71%-19.65M | -39.43%-52.56M | 2.40%-12.96M | -12.69M |
| Net non-operating interest income expense | 159.65%7.34M | 253.62%6.01M | 965.31%13.39M | 585.79%6.18M | 670.20%2.69M | 3,617.11%2.83M | 2,562.32%1.7M | 1,130.33%1.26M | 90,200.00%901K | 349K |
| Total other finance cost | -159.65%-7.34M | -253.62%-6.01M | -965.31%-13.39M | -585.79%-6.18M | -670.20%-2.69M | -3,617.11%-2.83M | -2,562.32%-1.7M | -1,130.33%-1.26M | -90,200.00%-901K | ---349K |
| Other net income (expense) | ||||||||||
| Income before tax | -12.17%-25.98M | -44.89%-26.01M | -74.22%-89.38M | -105.85%-24.82M | -90.03%-23.46M | -66.83%-23.16M | -37.85%-17.95M | -35.66%-51.3M | 9.19%-12.06M | -12.34M |
| Income tax | -55.08%53K | 16.00%29K | 1,288.24%236K | -73.33%-312K | 454.79%405K | 84.38%118K | -58.33%25K | -92.64%17K | -322.22%-180K | 73K |
| Net income | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M | -34.88%-51.32M | -22.25%-11.88M | -12.42M |
| Net income continuous Operations | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M | -34.88%-51.32M | 11.09%-11.88M | ---12.42M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M | -28.28%-51.32M | -1.73%-11.88M | -12.42M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | -59.68%1.52M | 0 | 0 | ||||
| Net income attributable to common stockholders | -11.83%-26.03M | -44.85%-26.04M | -69.62%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -50.55%-23.28M | -37.41%-17.98M | -20.73%-52.84M | 23.04%-11.88M | -12.42M |
| Basic earnings per share | 10.00%-0.54 | 24.00%-0.57 | -75.89%-2.43 | -54.58%-0.48 | -29.29%-0.63 | 1.12%-0.6 | -46.10%-0.75 | 19.56%-1.3816 | 48.72%-0.3105 | -0.4873 |
| Diluted earnings per share | 10.00%-0.54 | 24.00%-0.57 | -75.89%-2.43 | -54.58%-0.48 | -29.29%-0.63 | 1.12%-0.6 | -46.10%-0.75 | 19.56%-1.3816 | 48.72%-0.3105 | -0.4873 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
